CD68 and neoplasm: Marked CD68+ TAM infiltration following intravesical Bacillus Calmette-Guérin (BCG) immunotherapy appears to be associated with worse response to treatment and shorter relapse-free survival, however, the use of CD68+ cell density as a biomarker of tumor-induced inflammatory response necessitates further validation [135,136].